Tui left a family feeling "stressed and disheartened" after refusing to refund a £6,300 holiday on medical grounds. The ...

RAG-17 is an experimental RNA-targeting therapy designed to lower toxic SOD1 protein in people with SOD1-ALS. A six-person trial found RAG-17 was well tolerated, with no serious side effects. RAG-17 ...

Researchers have found that, with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use ...

Drug companies have quietly stepped back from development programs in long COVID and related conditions, leaving patients ...